Technical analysis for shorts & longs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technical analysis for shorts & longs

SPY 681.44

+1.6%

Nov 10 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Johnny Canuck who wrote (67525)

11/3/2025 1:15:30 PM

From: Johnny Canuck

of 67830

Kenvue Inc (KVUE)

+19.00%

Gapping up after Kimberly-Clark announced that it will acquire the company in a cash-and-stock deal valued at about $48.7 billion, creating a global health and wellness leader with 10 iconic billion-dollar brands. The merger is expected to generate $2.1 billion in annual synergies and become accretive to Kimberly-Clark’s adjusted EPS by the second year. Kenvue, which owns Tylenol and was spun off from Johnson & Johnson in 2023, has been under fire as of late after the Trump administration made connections between Tylenol usage in pregnancy and autism.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next